COKA YIP: Open Payments
NPI 1295915908 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,711 in 17 payments from 5 companies in 2025. Trend: 2023 $3,876 · 2024 $4,578 · 2025 $3,711
Consulting: $2,500Travel & lodging: $696Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $3,438 |
| GENZYME CORPORATION | 3 | $162 |
| Aimmune Therapeutics, Inc. | 1 | $42 |
| Ardelyx, Inc. | 1 | $40 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
Products named: TRULANCE, DUPIXENT, XIFAXAN, VOWST, IBSRELA, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
